Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Extra Strength Tylenol ads

This article was originally published in The Tan Sheet

Executive Summary

Extra Strength Tylenol ads: Referred to Federal Trade Commission by the National Advertising Division of the Council of Better Business Bureaus, NAD announced April 26. Challenged by Advil manufacturer American Home Products ("The Tan Sheet" April 15, In Brief), J&J's ads claim: "If you use ibuprofen and have an ulcer, Tylenol may be a better choice for you." J&J, according to NAD, "has chosen not to participate in the self-regulatory process," which would require the firm to provide evidence to substantiate the claim. NAD disagrees with McNeil's assertion that the issue was resolved in a 1987 court case. "The claims differ," says NAD, "particularly as to the expression of these products' relative differences and the levels of risk"...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS085354

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel